Patents by Inventor Jei-Ming Peng

Jei-Ming Peng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Suppression of cancer metastasis
    Patent number: 9764005
    Abstract: Methods of using fibrillar proteins are provided for suppressing cancer metastasis. Cancer metastasis is the most common cause of treatment failure and death in cancer patients. Tumor cell invasion and/or migration can be significantly inhibited after fibrillar proteins (rVP1, F-HSA, and F-BSA) treatment in vitro. In addition, rVP1 can significantly suppress murine and human breast cancer metastasis and human prostate and ovarian cancer metastasis in vivo while F-HSA can significantly suppress murine breast cancer metastasis.
    Type: Grant
    Filed: August 26, 2015
    Date of Patent: September 19, 2017
    Assignee: Academia Sinica
    Inventors: Shu-Mei Liang, Ching-Feng Chiu, Shao-Wen Hung, Jei-Ming Peng, Chi-Ming Liang
  • SUPPRESSION OF CANCER METASTASIS
    Publication number: 20160051634
    Abstract: Methods of using fibrillar proteins are provided for suppressing cancer metastasis. Cancer metastasis is the most common cause of treatment failure and death in cancer patients. Tumor cell invasion and/or migration can be significantly inhibited after fibrillar proteins (rVP1, F-HSA, and F-BSA) treatment in vitro. In addition, rVP1 can significantly suppress murine and human breast cancer metastasis and human prostate and ovarian cancer metastasis in vivo while F-HSA can significantly suppress murine breast cancer metastasis.
    Type: Application
    Filed: August 26, 2015
    Publication date: February 25, 2016
    Inventors: Shu-Mei Liang, Ching-Feng Chiu, Shao-Wen Hung, Jei-Ming Peng, Chi-Ming Liang
  • SUPPRESSION OF CANCER METASTASIS
    Publication number: 20120309682
    Abstract: Methods are provided for suppressing cancer metastasis. Cancer metastasis is the most common cause of treatment failure and death in cancer patients. Tumor cell invasion and/or migration can be significantly inhibited after fibrillar proteins (rVP1, F-HSA, and F-BSA) treatment in vitro. In addition, rVP1 can significantly suppress murine and human breast cancer metastasis and human prostate and ovarian cancer metastasis in vivo while F-HSA can significantly suppress murine breast cancer metastasis. Compositions of fibrillar proteins as anti-cancer metastasis therapeutics and methods of use thereof are provided herein.
    Type: Application
    Filed: November 19, 2010
    Publication date: December 6, 2012
    Inventors: Shu-Mei Liang, Ching-Feng Chiu, Shao-Wen Hung, Jei-Ming Peng, Chi-Ming Liang
  • Apoptosis-inducing polypeptides
    Patent number: 7700730
    Abstract: An isolated water-soluble VP1 polypeptide of foot-and-mouth disease virus and a nucleic acid encoding the polypeptide. Also disclosed are a pharmaceutical composition containing the polypeptide or nucleic acid and related methods of inducing apoptosis and treating an apoptosis-related disorder.
    Type: Grant
    Filed: December 3, 2007
    Date of Patent: April 20, 2010
    Assignee: Academia Sinica
    Inventors: Shu-Mei Liang, Jei-Ming Peng, Chi-Ming Liang
  • Apoptosis-inducing polypeptides
    Patent number: 7488800
    Abstract: An isolated water-soluble VP1 polypeptide of foot-and-mouth disease virus and a nucleic acid encoding the polypeptide. Also disclosed are a pharmaceutical composition containing the polypeptide or nucleic acid and related methods of inducing apoptosis and treating an apoptosis-related disorder.
    Type: Grant
    Filed: November 30, 2007
    Date of Patent: February 10, 2009
    Assignee: Academia Sinica
    Inventors: Shu-Mei Liang, Jei-Ming Peng, Chi-Ming Liang
  • APOPTOSIS-INDUCING POLYPEPTIDES
    Publication number: 20080188410
    Abstract: An isolated water-soluble VP1 polypeptide of foot-and-mouth disease virus and a nucleic acid encoding the polypeptide. Also disclosed are a pharmaceutical composition containing the polypeptide or nucleic acid and related methods of inducing apoptosis and treating an apoptosis-related disorder.
    Type: Application
    Filed: November 30, 2007
    Publication date: August 7, 2008
    Applicant: Academia Sinica
    Inventors: Shu-Mei Liang, Jei-ming Peng, Chi-Ming Liang
  • APOPTOSIS-INDUCING POLYPEPTIDES
    Publication number: 20080152666
    Abstract: An isolated water-soluble VP1 polypeptide of foot-and-mouth disease virus and a nucleic acid encoding the polypeptide. Also disclosed are a pharmaceutical composition containing the polypeptide or nucleic acid and related methods of inducing apoptosis and treating an apoptosis-related disorder.
    Type: Application
    Filed: December 3, 2007
    Publication date: June 26, 2008
    Applicant: Academia Sinica
    Inventors: Shu-Mei Liang, Jei-Ming Peng, Chi-Ming Liang
  • Apoptosis-inducing polypeptides
    Patent number: 7323546
    Abstract: An isolated water-soluble VP1 polypeptide of foot-and-mouth disease virus and a nucleic acid encoding the polypeptide. Also disclosed are a pharmaceutical composition containing the polypeptide or nucleic acid and related methods of inducing apoptosis and treating an apoptosis-related disorder.
    Type: Grant
    Filed: June 8, 2004
    Date of Patent: January 29, 2008
    Assignee: Academia Sinica
    Inventors: Shu-Mei Liang, Jei-Ming Peng, Chi-Ming Liang
  • Apoptosis-inducing polypeptides
    Publication number: 20050058654
    Abstract: An isolated water-soluble VP1 polypeptide of foot-and-mouth disease virus and a nucleic acid encoding the polypeptide. Also disclosed are a pharmaceutical composition containing the polypeptide or nucleic acid and related methods of inducing apoptosis and treating an apoptosis-related disorder.
    Type: Application
    Filed: June 8, 2004
    Publication date: March 17, 2005
    Applicant: Academia Sinica
    Inventors: Shu-Mei Liang, Jei-Ming Peng, Chi-Ming Liang